Related by context. All words. (Click for frequent words.) 74 Alton Boynton 72 Neil K. Warma 71 Mr. Zami Aberman 70 Georges Gemayel 70 Zami Aberman 70 Howard H. Pien 70 Daniel Junius 69 Dr. Philip Toleikis 69 Mark A. Sirgo 69 Juergen Engel Ph.D. 69 Tod Woolf Ph.D. 69 Amir Avniel 68 PharmD Ardea 68 Michael Fonstein Ph.D. 68 Hakan Edstrom 68 Elisabeth Lindner CEO 68 David Aviezer 68 Errol De Souza 68 Michael H. Tardugno 67 Tom van Aken 67 Dr. Masamichi Koike 67 Avtar Dhillon MD 67 Dr. Kobi Vortman 67 Joshua Boger Ph.D. 67 Christoph Westphal MD Ph.D. 67 Joanna Horobin MD 66 Emer Leahy 66 Nicholas Nicolaides 66 Antony Koblish President 66 Carl Spana Ph.D. 66 Gord Froehlich President 66 Dr. Wayne Danter 66 Zami Aberman Pluristem 66 Ph.D. Targacept 66 Jeffrey M. Ostrove 66 Drew Fromkin President 66 Keith Katkin 66 Dr. Aiping Young 66 Dr. Bassam Damaj 66 Dr. Fahar Merchant 66 Mark Leuchtenberger President 66 Edward Lanphier Sangamo 66 Safi Bahcall Ph.D. 66 Mr. Armando Anido 66 Dan Passeri 66 Sheldon Berkle 66 Donald L. Drakeman 66 James Manuso 66 Vincent Milano ViroPharma 66 Spiro Rombotis President 65 Carl A. Pelzel 65 J. Mazzo Ph.D. 65 Per Olof Wallström 65 Michael V. Novinski 65 Patrice Milos 65 commented Nicholas Landekic 65 Mitchel Sayare 65 stated Dominique Costantini 65 Igor Gonda 65 Igor Gonda Ph.D. 65 Jens Schneider Mergener 65 Quay MD Ph.D. 65 Steven A. Kriegsman 65 Mark HN Corrigan 65 Mr. Weidong Yin 65 Kenneth I. Moch 65 Christopher J. Schaber 65 Dr. Horst Zerbe 65 Michel Morre DVM 65 James SJ Manuso 65 Uli Hacksell Ph.D. 65 Barry D. Quart 65 Tod Woolf 65 Tim Mayleben 65 Sol J. Barer 65 Steve Worland Ph.D. 65 Pedro Lichtinger 65 Kirsten Drejer 65 Anthony Giovinazzo 64 Stephen Ghiglieri 64 Juergen Engel 64 Paul Laikind 64 Dan Passeri Curis 64 Robert L. Bratzler 64 J. Donald deBethizy 64 Jan Egberts 64 Thomas Okarma 64 Haro Hartounian Ph.D. 64 Mr. Frank Menzler 64 Kleanthis G. Xanthopoulos Ph.D. 64 Dr. Amnon Gonenne 64 Arno Therapeutics 64 kidney urologic 64 Steven Kriegsman 64 Ira L. Goldknopf 64 Anker MD Ph.D. 63 Ron Bentsur 63 Jay Flatley Illumina 63 Dr. Randall Yatscoff 63 Mark Sirgo 63 Submits Response 63 Garo H. 63 novel immunotherapies 63 Rolland Yves Mauvernay 63 Jean Luc Bélingard Chairman 63 Kathleen Danenberg 63 Dino Dina 63 Daniel Passeri Curis 63 Dr. Rahul Singhvi 63 molecular chaperone regulation 63 Mark Leuchtenberger 63 Radu Leca 63 Safi Bahcall 63 Dr. Henrich Guntermann 63 Karin Eastham 63 Michael Fonstein 63 Mr. Luc Mainville 63 Fran DiNuzzo 63 Dr. Isa Odidi 63 Malcolm Skolnick CytoGenix 63 Harry Palmin President 63 Yves Rosconi President 63 Jim Sulat 63 Adrian Hobden Ph.D. 63 Rosen ViroPharma 63 Aeolus Pharmaceuticals Announces 63 Yves Rosconi 63 Damian Marron 63 Catherine M. Burzik 62 Robert D. Battis 62 Dr. Bruno Giannetti 62 Brian JG Pereira 62 John Maraganore Ph.D. 62 Kazumi Shiosaki 62 Alexis Borisy President 62 Anthony J. Armini 62 CCR9 antagonist 62 Tony Milici 62 Stephen M. Simes 62 John R. Plachetka 62 Jonah Shacknai Chairman 62 Mr. Yves Rosconi 62 Leonard P. Shaykin 62 Mark Pykett 62 Begins Dosing 62 Initiates Phase II 62 Christian Itin 62 Jeffrey H. Buchalter 62 HuCNS SC ® 62 Keith Katkin AVANIR 62 Gerd Zettlmeissl 62 Bruce Galton 62 Vaughn M. Kailian 62 Lonnie Moulder 62 Ms. Gerri Henwood 62 Gunther Braun 62 Dr. Boro Dropulic 62 Steven R. Deitcher 62 David H. Fater 62 Harold Van Wart 62 Fischer GenVec 62 Richard Garr Neuralstem 62 Robert J. Capetola 62 Loïc Maurel MD 62 Anna Gluskin 62 JJ Finkelstein 62 Ralph Makar 62 Dr. Raafat Fahim 62 Kuslima Shogen 62 Dr Mario Polywka 62 Timothy P. Walbert 62 Neogenix 62 Christian Homsy 62 developing Surfactant Therapies 62 Reports Preclinical Data 62 Patrik De Haes 62 William H. Rastetter 62 Barry Selick 62 André Michel Ballester 61 Haim Aviv 61 J. Melamede 61 Nicholas Landekic 61 Timothy P. Clackson 61 Initiates Enrollment 61 Ron Najafi 61 Jean Jacques Bienaime 61 Ulrich Dauer CEO 61 Tomas Leanderson 61 David Sidransky 61 t2cure GmbH 61 Anders Essen Moller 61 Daniel Vasella Chairman 61 symbol AVXL 61 Elisabeth Lindner 61 Michele Garufi Chairman 61 Selecta Biosciences 61 Blum Cytokinetics 61 oral picoplatin 61 GVAX ® 61 Onno van de Stolpe 61 Gil Van Bokkelen 61 Armen PhD 61 Martin Nicklasson CEO 61 Kevin Rakin 61 Zafiris G. Zafirelis 61 Cerimon Pharmaceuticals Inc. 61 manufactures minimally invasive 61 Richard Azani 61 Marc Oczachowski EDAP 61 Margaret Foti 61 Jeff Morhet Chairman 61 Jean Pierre Sommadossi 61 Kathleen Karloff 61 Dr. Hassan Salari 61 Don deBethizy 61 Bassil Dahiyat Ph.D. 61 MS Koly 61 Dr. Arndt Schottelius 61 successfully commercialize Iluvien 61 Martin Nicklasson 61 Dr. Avtar Dhillon 61 Randy Lubinsky 61 Chang Ahn Rexahn 61 HDL Selective Delipidation 61 Steven B. Ratoff 61 Initiates Clinical Trial 61 Presents Preclinical 61 About Positron Positron 61 Duane DeSisto 61 Shai Gozani 61 Michael Kishbauch 61 Eamonn Hobbs 61 Dr. Yves Fradet 60 Sylvie Gregoire 60 Steven Nichtberger MD 60 Gregory A. Demopulos 60 Hoyoung Huh MD Ph.D. 60 Mihael Polymeropoulos MD 60 Daniel H. Movens 60 Tuan Ha Ngoc 60 Philippe Calais 60 Anat Cohen Dayag 60 Initiates Clinical 60 Dr. Frank DiCosmo 60 Submits IND 60 Inc. Nasdaq TNGN 60 Iris Loew Friedrich 60 Personalized Immunotherapy 60 ThromboGenics commenting 60 Mr. Pierre Laurin 60 Vincent Mutel CEO 60 Theodore A. Boutacoff 60 Theodore Zucconi Ph.D. 60 June Almenoff MD 60 Patrick Balthrop 60 Adrian Hobden 60 Nicole Onetto MD 60 Stuart Essig Integra 60 Gearóid Faherty Chairman 60 Timo Veromaa 60 Daniel O. Wilds 60 Eric von Hofe 60 Jan Keltjens President 60 Karl Gemperli 60 Martin Gerstel 60 Ryuji Ueno 60 Francois Nader 60 Sachiko Kuno 60 Pierre Larochelle 60 Paolo Pucci chief 60 MediGene focuses 60 Paul C. Desjourdy 60 Dr. Michelle Berrey 60 Alan Kingsman 60 Dr. Blobel 60 Greg Wujek 60 Richard Treagus 60 Sam Owusu Akyaw 60 David Bupp Neoprobe 60 Catherine Burzik 60 Alex Kotzer 60 EVIZON TM 60 Haig Keledjian 60 Wolfgang Renner 60 Sven Andreasson 60 humanized therapeutic 60 Joseph Belanoff MD 60 Dr. Marlies Sproll 60 Dr. Sidransky 60 Shai N. Gozani 60 novel therapeutic antibodies 60 Anthony DiTonno President 60 please visit http:/www.sunesis.com 60 Gary Dreher AMDL 60 Jeff Morhet 60 Murray Tekmira 60 Prabhavathi Fernandes 60 Sijmen de Vries 60 Ueno founded 60 developing ostarine selective 59 Regado Biosciences 59 Francis DiNuzzo 59 Derek Hennecke 59 Loic Maurel 59 pharmacogenomic translational research 59 Gerard E. Puorro 59 NicOx commented 59 Elisabeth Lindner President 59 James DeOlden 59 Tomas Puusepp 59 Professor Silviu Itescu 59 Joseph V. Gulfo 59 Ronald Brus 59 Dr. Othmar Pfannes 59 Richard Faleschini 59 Simon Moroney 59 Marc Oczachowski 59 Brown B.Sc. MBA 59 Charlotte Keywood 59 Diane S. Goostree 59 Hoyoung Huh 59 commented Mitchel Sayare 59 Robert J. Broeze 59 Christopher Anzalone Arrowhead 59 Pedro Lichtinger Optimer 59 Torbjorn Bjerke 59 Rob Cascella President 59 Ph.D. MD hc 59 A. Pontius 59 Patrick Fourteau 59 Fereydoun Firouz 59 Nanobiotix 59 Glenn A. Oclassen 59 Tony Bihl 59 GENR 59 BY EDWARD ZERIN 59 Ed Quilty 59 Anders Lonner 59 Elkan Gamzu Ph.D. 59 Louis P. Scafuri 59 Thomas Ramdahl 59 Chris D' Couto 59 Daniel Tasse 59 David Kaysen 59 Homi Shamir president 59 Dave Holveck 59 MD Ph.D. Kosan 59 Pascal Pfister 59 Inc. OTCBB PLRS 59 James Sapirstein 59 dermatology gastroenterology 59 Sachiko Kuno Ph.D. 59 H. Willard Flamel 59 Rahul Singhvi 59 Crofelemer budesonide foam 59 David P. Holveck 59 Bernd Seizinger 59 fusion enhancers 59 Jorn Aldag 59 Sven Ruder 59 Xcytrin R 59 Cardioxyl 59 SNT-MC#/idebenone 59 Daniel J. Abdun 59 Vicente Anido Jr. 59 MD Geron 59 Ray Salemme 58 Joe Rotunda EZCORP 58 essential thrombocythemia ET 58 Jal S. Jassawalla 58 John Kallassy 58 Jeffrey Buchalter 58 MD Ph.D. NeuroMetrix 58 Faheem Hasnain 58 John C. Ruckdeschel 58 Syndax 58 Frank Verwiel MD 58 Advanced Biotherapy 58 Jean Luc Belingard Chairman 58 IMPDH inhibitor 58 TKM PLK1 58 Scott Pancoast Lpath 58 Edward M. Rudnic 58 Torbjörn Bjerke 58 Alexei Marko 58 ImmunoCellular Therapeutics 58 Phytomedics Inc. 58 Kevetrin TM 58 John F. Thero 58 Don Kiepert President 58 ERYtech Pharma 58 Gregory D. Casciaro 58 Yaffa Beck 58 lymphoma myeloma 58 Aviptadil 58 Nicholas Borys 58 Remi Barbier 58 Michael Tzannes 58 Patrick Schwarz Schuette 58 Loretta M. Itri 58 JJ Finkelstein RegeneRx 58 Mr. Jassawalla 58 IRX Therapeutics 58 Therion Biologics Corporation 58 Etubics 58 AAG geldanamycin analog 58 Jan Turek Biolex 58 Rik J Deitsch 58 Eckard Weber 58 Dr. Kai Lindevall 58 Elliott Sigal 58 Mr. Mordock 58 Chirico Immucor President 58 HemaQuest 58 GVAX R 58 Initiates Phase III 58 Dr. Anil Diwan 58 Bayhill Therapeutics 58 Robert D. Heuchan 58 Peter Riehl Stellar 58 ESBATech AG 58 Jim DeMesa 58 Nancy Wysenski 58 CEO Tod Woolf 58 Peer Schatz QIAGEN 58 Walter Witoshkin 58 Brad Bolzon 58 Theron E. Odlaug 58 Joseph K. Belanoff 58 Pierre Cassigneul 58 Medistem Laboratories 58 Antenor Silva President 58 M.D. Ph.D. 58 Joern Aldag President 58 Trofex 58 BioLife Solutions 58 Abhay Joshi 58 Harold D. Stolovitch 58 Dees PhD 57 Amgen discovers develops 57 Homi Shamir 57 Mr. Xiangzhi Chen 57 CYT# potent vascular disrupting 57 Monoclonal antibody 57 Stephen J. Browand 57 Dennert O. Ware 57 ThromboGenics commented 57 Albuferon albinterferon alfa 2b 57 SinuNase ™ 57 Louis Drapeau 57 Manja Bouman CEO 57 Budesonide foam crofelemer 57 KRYSTEXXA TM pegloticase 57 Dr. Wang Changli 57 Stephen K. Onody 57 Dale Pfost 57 pluripotent human 57 ENABLE Phase 2 57 Dr. Dov Tamarkin 57 Gary Restani 57 novel emulsion formulation 57 Orville G. Kolterman 57 Frank DeLape 57 Andrew Swarthout P.Geo 57 Friedhelm Blobel 57 CEO Farhad Moghadam 57 Robert L. Chioini 57 Mr. Xiaodong Wu 57 Robin Stracey 57 Trophos 57 Kevin Hrusovsky 57 CTAP# Capsules 57 Sander van Deventer 57 thetreatment 57 subsidiaries visit http:/www.apricusbio.com 57 TransVax ™ 57 Dr. Steven Tsengas 57 George J. Vergis 57 Clay B. Siegall 57 Dirk Kuyper 57 Louis Drapeau InSite 57 J. Drachman 57 Peter A. Lankau 57 Hugues de Bantel 57 Mesoblast Limited ASX MSB 57 MD Halozyme 57 Gonzague Issenmann 57 Arthur Bedrosian president 57 Onyx Pharmaceuticals Announces 57 Matthew Laudon 57 Jure Sola Chairman 57 Daphne Preuss 57 Roger Boissonneault 57 treat chronic sinusitis 57 Christopher L. Coccio 57 Æterna Zentaris 57 Renaat Van den Hooff 57 Candace Kendle PharmD 57 Arete Therapeutics 57 rotavirus shingles 57 Tapestry Pharmaceuticals 57 Adnan Mjalli 57 Michael L. Kranda 57 J. Ladd Greeno 57 Prof. Pnina Fishman 57 Adelene Q. Perkins 57 John Langstaff Cangene 57 adult mesenchymal stem 57 Teresa Cascioli Chair 57 David Crockford RegeneRx 57 Tovaxin TM 57 Joseph Feczko 57 Jose Mas MasTec 57 Haghighi Mood 57 Deborah Rathjen 57 Posiphen TM 57 ® bortezomib 57 Karl B. Gemperli 57 novel trazodone formulation 57 Branislav Vajdic Ph.D. 57 anticoagulant reversing agent 57 L. Berns 57 Bernhard Steiner 57 TRIOLEX HE# APOPTONE HE# 57 Oracea TM 57 delivers fluocinolone acetonide FA 57 Dr. Manuso 57 Randall Schatzman 57 Cx# [002] 57 Steven Arikian 57 Discoveries Tomorrow 57 Eric Krasnoff Chairman 57 oncolytic virus therapies 57 SUTENT ® 57 hyperphenylalaninemia HPA due 57 Stanley Erck 57 http:/www.vivus.com 57 Matthias L. Wolfgruber 57 initiated Phase Ib 57 Drew Fromkin 57 WILEX AG 57 NASDAQ INFI 57 Friedhelm Blobel Ph.D. 57 INSPIRE Trial Phase III 57 David Robbins Micronetics 57 triggers apoptosis programmed 57 Claes Glassell 57 Nereus Pharmaceuticals 57 Jacques Séguin MD Ph.D. 57 Andy Boorn 57 G#DT 56 Staph Leavenworth Bakali 56 Masafumi Nogimori 56 Dr. Shrotriya 56 Marillion Pharmaceuticals 56 Maxine Gowen Ph.D. 56 Mark L. Faupel 56 Dani Bolognesi 56 Frank A. Lodzinski 56 InVasc 56 Glenn Nedwin 56 David Spaight 56 OMNARIS HFA 56 novel peptides 56 Jan Keltjens 56 Greg Lucier Invitrogen 56 Creabilis Therapeutics 56 Saegis Pharmaceuticals 56 adipose derived stem cell 56 Richmond McKinnish Carlisle 56 Chain Intellect 56 Dr. Ayalew Tefferi 56 Erkki Ruoslahti 56 R sorafenib tablets 56 Dr. Maraganore 56 LensAR 56 Dr. Ted Prociv 56 Hem Pandya 56 4SC commented 56 rhIGF-I/rhIGFBP-3 56 J. Schaber PhD 56 Joseph Rubinfeld 56 Raghu Kilambi 56 Syntaxin 56 acetonide FA 56 Nicholas Galakatos 56 Phase #b/#a clinical 56 perianal fistulas 56 SNS# T 56 cellular immunotherapy 56 Norbert Riedel 56 demonstrated antitumor activity 56 adrenergic regulation 56 Jordan Estra 56 Thomas CK Yuen 56 Euan Thomson 56 TELINTRA R 56 Successfully Completes Phase 56 Cellerant 56 Bioral Amphotericin B 56 Amgen discovers develops manufactures 56 TransVax 56 Dr. Stylli 56 DCVax R 56 Inc. OTCBB BMSN 56 IG HCR ;) CO 56 Harold H. Shlevin 56 Anders Hedegaard 56 Sayan Navaratnam 56 Alexis V. Lukianov 56 Barry H. Golsen 56 progressive metastatic prostate 56 VentiRx 56 Zemiva TM 56 AGY Therapeutics 56 metaglidasen 56 H. Kirn 56 Sudhir Agrawal D.Phil 56 Fred Eshelman PPD 56 Kiadis Pharma 56 Pepscan Therapeutics 56 Melville Engle 56 David Schenkein MD 56 Kip Hallman 56 rALLy clinical trial 56 M# rationally 56 HEPLISAV TM hepatitis B 56 Nanobody R 56 Catalyst Biosciences 56 Clay Siegall 56 regenerative medicine therapies 56 Bret Bader 56 GRNOPC1 contains 56 Ludo Reynders 56 Mr. Jinsheng Ren 56 Thomas Sandgaard 56 ADVEXIN therapy 56 Anna Gluskin Generex 56 Antony Koblish 56 Bradbury Amylin 56 Justin Belobaba President 56 Mohan Maheswaran 56 Stefan Widensohler 56 David Sidransky MD 56 Swisher Sunesis 56 JD Avigen 56 Stemedica 56 Biolipox 56 A. Sedor 56 Ismail Kola 56 Altair Therapeutics 56 Frank Laukien 56 Critchfield MD 56 Shlomo Yanai Teva 56 Nitric Bio 56 JAK#/JAK# inhibitor CYT# 56 Gerald T. Proehl 56 estrogen receptor beta agonist 56 Doug Godshall 56 Burt Adelman 56 Zeb Horowitz 56 immatics 56 commercialize deforolimus 56 Omthera 56 Provectus Pharmaceuticals specializes 56 Jack Lief Arena 56 Dr. Yatscoff 56 Walter Geldenhuys 56 Agios Pharmaceuticals 56 Inc. NASDAQ ICGN 56 treats acute lymphoblastic 56 Zavesca r 56 ThermoDox ® clinical 56 Pieter Muntendam 56 Mr. Rosconi 56 solid tumors ZYBRESTAT 56 Charles Fust 56 Dr. Lorne Tyrrell 56 Mr. Fater 56 PrimeGen Biotech 56 Mark Emalfarb 55 Pervasis 55 Archexin 55 Dr. Geert Cauwenbergh 55 Dominique Costantini 55 neuropathic pain spasticity 55 Alex Lukianov Chairman 55 Martyn Coombs 55 YONDELIS 55 Kuslima Shogen Alfacell 55 leading oral taxane 55 Immunex Corporation 55 Dr. Scangos 55 rasagiline tablets 55 proprietary intravenous formulation 55 Kevin Sharer Amgen 55 Mihir Taneja 55 Justus Homburg 55 TESARO 55 Lars Ekman 55 Orqis Medical 55 LAB CGRP 55 MCSP respectively 55 Louis Chenevert credited 55 George Perros Greystone 55 FOLOTYN ® 55 Steve Giordanella 55 Kenneth J. LeStrange 55 Ron Lipstein 55 NV1FGF 55 Induced pluripotent stem cells 55 Craig Tuttle Transgenomic 55 Anders Ekblom 55 ADAGEN 55 MKC# MT 55 William Moffitt Nanosphere 55 Ora Hirsch Pescovitz 55 Hoji Alimi founder 55 ProNAi 55 Mr. Mingwang Lu 55 Dr. Kshitij Mohan 55 Yuval Cohen 55 Rene Boisvert 55 treating neuropathic pain 55 Pramod Bhasin Genpact 55 Inc. OTCBB SCII 55 M. Bradbury Amylin 55 website http:/www.celsion.com 55 commercial bioproduction 55 Sidney Himmel 55 CMV vaccine 55 Gilles Gagnon 55 Peptimmune 55 Ms. Zhilin Li 55 Elafin 55 THR beta agonist 55 Sharon Hesterlee vice 55 Dov Ofer 55 Paul Cofoni CACI 55 Cerimon Pharmaceuticals 55 Eran Broshy 55 Julie Fleshman 55 Nasdaq CYCC Nasdaq CYCCP 55 John McDermott Endologix 55 Steve Cartt Executive 55 Chuck Mottley 55 Achieves Primary Endpoint 55 commercialize CorMedix drug 55 hypoxia activated prodrug 55 oral prodrug 55 orally administered inhibitor 55 Jean Pierre Sommadossi Ph.D. 55 Covalon Technologies 55 Morten Jurs 55 P. Byrnes Lincare 55 OncoVex 55 Nickolas Papadopoulos 55 vaccine GMK 55 OvaRex R 55 LymphoStat B belimumab 55 Trofex TM 55 Peer Schatz 55 MOLOGEN AG 55 p# inhibitor 55 CRMD# 55 Jean Loup Romet 55 Joe Gromek Warnaco 55 Howard Birndorf 55 HGS ETR1 mapatumumab 55 Biopharm Development 55 Henry F. Blissenbach 55 BB Sahay 55 Jim Leto GTSI 55 Andrew Makrides 55 Raymond Cannefax 55 Jean Luc Belingard 55 Jason K. Wadzinski 55 Dick Hipple 55 Elkan Gamzu 55 Len Perham MoSys 55 Medgenics 55 CA9 SCAN 55 Raymond P. Warrell 55 Evoltra ® 55 targeted radiotherapeutic 55 Elazar Rabbani 55 Multi Lineage Progenitor 55 tumor immunology 55 Dennis Podlesak 55 Roberto Crea 55 Brian Pockett 55 van Duzer 55 Procyon Biopharma 55 Catherine Burzik KCI 55 Conatus Pharmaceuticals 55 Tectin TM 55 Tikvah Therapeutics 55 Mr. Kriegsman 55 Bruce Weitzberg 55 severe malignant osteopetrosis 55 Relypsa 55 NOXXON 55 Barry Selick Threshold 55 Simon Sturge 55 Mr. Yves Marmet 55 Aggrastat ® tirofiban hydrochloride 55 Karen Antman 55 Myles S. Odaniell 55 Guy Nissenson 55 treat secondary hyperparathyroidism 55 neurology immunology 55 EnVivo 55 Donald Brisebois 55 OHR/AVR# 55 Mark Emkjer 55 Dr. Wolfgang Wein 55 Dr. Ogan Gurel 55 Jim Musick Vitro 55 Chemokine Therapeutics 55 XTLbio 55 Yuval Viner BOS 55 Pervasis Therapeutics Inc. 54 including eniluracil ADH 54 Altastaph 54 Mohammad Azab MD 54 therapeutic monoclonal antibodies 54 Alan Milinazzo 54 LPLD 54 MKC# 54 David Moskowitz GenoMed 54 selective angiogenic kinase inhibitor 54 JenaValve 54 Somatuline Depot 54 Kevin Buchi 54 SMT C# 54 Prima BioMed 54 factor TNF receptor 54 candidate TNFerade biologic 54 Jacob Inbar 54 Ofer Haviv Evogene 54 Ellen R. Hoffing 54 Lonnel Coats 54 Tobira Therapeutics Inc. 54 Andre Terzic 54 inhaled liposomal ciprofloxacin 54 Raymond T. Bartus 54 Farhad Abasov Allana 54 products BioTime develops 54 Pascal Delmas 54 Paul Bisaro Watson 54 R#/MEM # 54 Diffusion Pharmaceuticals 54 candidate REP# 54 Bioaccelerate compounds under 54 Dr. Cauwenbergh 54 Ryo Kubota MD Ph.D. 54 Civacir 54 lymphomas leukemias 54 Dr. Siva Sivananthan 54 Glen de Vries 54 Mihael Polymeropoulos 54 dyslipidemia hypertension diabetes 54 BioNumerik 54 Steven Ratoff 54 StemEx R 54 Bayer HealthCare Onyx Pharmaceuticals 54 Nick Konidaris ESI 54 Bob Butchofsky 54 Giulio Cossu 54 tezampanel NGX# 54 ASONEP TM 54 VIRxSYS 54 Jay Freeland FARO 54 James S. Manuso 54 Vern Heinrichs 54 Empatic ™ 54 Mr. Hongwei Qu 54 FoldRx Pharmaceuticals Inc. 54 sunitinib Sutent 54 Joe Carleone 54 Steven Tregay 54 Linda Thorstad 54 Perforomist ™ Inhalation Solution 54 Lisa N. Drakeman 54 Lixivaptan 54 Sean Roosen President 54 Lars Kongsbak 54 autologous adult 54 Dr. Hombeck 54 Lutz Giebel 54 Boyd Soussana 54 Mr. Bentsur 54 Jai Nagarkatti 54 Harold Varmus MD 54 Klaus Schollmeier 54 Lisa Krinsky 54 catheter occlusion 54 Maurizio Vecchione 54 Tobira Therapeutics 54 compound INCB# 54 Matthew Emmens 54 Silodosin 54 Tarvacin Anti Cancer 54 Ms. Katen 54 ovarian prostate 54 Doron Birger 54 Goran Ando 54 Gary F. Burbach 54 Tramiprosate ALZHEMED TM 54 Fabian Tenenbaum 54 ASONEP ™ 54 VitiGam TM 54 familial hypercholesterolemia FH 54 Meritage Pharma 54 Ben Shappley 54 SNT MC# 54 Michael Mathews interCLICK 54 Phase III ADT 54 refractory colorectal cancer 54 Philippe Archinard 54 Valentin P. Gapontsev 54 oral talactoferrin 54 T. Flavin 54 include ColorectAlert TM 54 Perforomist TM formoterol fumarate 54 Muraglitazar 54 Terje Storeng Odfjell 54 Eric Stonestrom Airspan 54 EnzymeRx 54 Combivir Kivexa 54 Jonathan Houssian 54 Regenerative Cell 54 ImmunoVEX HSV2 54 Litx 54 Rachel Ballard Barbash 54 Jane Hsiao 54 VisEn Medical 54 collagen vascular 54 Jack Kraeutler 54 ViOptix 54 VasoGenix Pharmaceuticals 54 Ben Binninger 54 Stan Yakatan 54 Please visit www.antisoma.com 54 Liposomal Grb 2 54 Salix Pharmaceuticals Announces 54 William Freytag 54 GENASIS 54 Sernova 54 Herbert Fritsche 54 Jim Wachtman President 54 Hoji Alimi 54 cMET 54 Daniel M. Skovronsky 54 Al Altomari 54 pharmacokinetic PK study 54 Camillo Ricordi MD 54 Matthew Schissler 54 Vance Vanier 54 Angelo C. Malahias 54 Peter Burlage 54 KuDOS 54 Desmond Ayim Aboagye 54 huC# DM4 54 trastuzumab DM1 T DM1 54 Mersana 54 Telatinib 54 Martin Madaus Millipore 54 Igeneon 54 PNT# 54 Lorin Krueger Winland 54 recombinant PSMA vaccine 54 Organ Regeneration Platform 54 HCV protease inhibitors 54 DPX Survivac 54 Ven Côté 54 Paul Barbas DPL 54 Renaud Beauchesne 54 Hank Nordhoff 54 Ele Ferrannini 54 Henrich Guntermann 54 BioRexis 54 R Bortezomib 54 Daniel Ash CelLynx 54 MAGE A3 ASCI 54 Gamida Cell 54 Novosom 54 Dennis Eidson Spartan 54 oral salmon calcitonin 54 Michael J. Luttati 54 Dr. Deborah Dunsire 54 Aegera 54 FluoroPharma 54 Lawrence Siebert Chembio 53 Generx TM 53 semi synthetic lipoglycopeptide 53 Jay Lichter 53 hepatocellular carcinoma liver 53 Amorcyte